Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Media Partners
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Media Partners
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Interventional Cardiology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
CALIPSO Trial: Breaking News for EuroPCR
1
Mins
May 2024
The CALIPSO trial has unveiled evidence supporting the use of optical coherence tomography in guiding percutaneous coronary intervention for moderate to severe calcified lesions.
Read more
1
Mins
16th May 2024
CALIPSO Trial: Breaking News for EuroPCR
The CALIPSO trial has unveiled evidence supporting the use of optical coherence tomography in guiding percutaneous coronary intervention for moderate to severe calcified lesions.
1
Mins
16th May 2024
DOCTORS-LM Trial: Breaking News from EuroPCR 2024
A recent randomised open-label trial reveals important findings on the efficacy of optical coherence tomography in guiding angioplasty for left main coronary artery lesions.
1
Mins
15th May 2024
NOTION-2 Trial: Breaking News from EuroPCR 2024
The NOTION-2 trial is a pivotal study that focused on low surgical risk patients aged 75 years or younger, including both tricuspid and bicuspid aortic stenosis (AS) cases…
1
Mins
15th May 2024
REC-CAGEFREE II Trial: Breaking News from EuroPCR 2024
Results of the REC-CAGEFREE II trial were presented today at EuroPCR by Ling Tao, FAHA Xijing hospital, Xi’an, China on behalf all REC-CAGEFREE II investigators….
1
Mins
14th May 2024
Transcatheter Valve and Vessels Trial: Breaking News from EuroPCR 2024
The Transcatheter Valve and Vessels (TCW) Trial, the first dedicated randomised, international study in patients with both aortic stenosis and advanced coronary disease, has delivered new insights…
1
Mins
14th May 2024
Advanced Diagnostic Strategy for Chronic Coronary Syndromes: Breaking News from EuroPCR 2024
A groundbreaking study, the AID-ANGIO, has revolutionised the diagnostic approach to chronic coronary syndromes…
1
Mins
15th September 2022
Physical Function and Cardiovascular Disease Events in Older Adults
The prognostic ability of traditional cardiovascular disease risk factors weakens as a function of age. Read to find out more…
1
Mins
15th September 2022
Sex-Specific Risk Stratification in Non-ST-segment Elevation Acute Coronary Syndrome
Researchers evaluated the sex-specific performance of the GRACE 2.0 score in non-ST-segment elevation acute coronary syndrome…
Loading posts...
1
2
3
…
5
Next »